Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study

Abstract Background The clinical value of blood eosinophils and their stability in chronic obstructive pulmonary disease (COPD) remains controversial. There are limited studies on association between the stability of blood eosinophils in acute exacerbation of COPD (AECOPD) and clinical outcomes. Thi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yanan Cui, Wenye Zhang, Yiming Ma, Zijie Zhan, Yan Chen
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/98b9ce1a4842486e8cacc243d007e447
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:98b9ce1a4842486e8cacc243d007e447
record_format dspace
spelling oai:doaj.org-article:98b9ce1a4842486e8cacc243d007e4472021-11-28T12:29:12ZStability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study10.1186/s12931-021-01888-51465-993Xhttps://doaj.org/article/98b9ce1a4842486e8cacc243d007e4472021-11-01T00:00:00Zhttps://doi.org/10.1186/s12931-021-01888-5https://doaj.org/toc/1465-993XAbstract Background The clinical value of blood eosinophils and their stability in chronic obstructive pulmonary disease (COPD) remains controversial. There are limited studies on association between the stability of blood eosinophils in acute exacerbation of COPD (AECOPD) and clinical outcomes. This study aimed to evaluate the stability of blood eosinophils in hospitalized AECOPD and its relationship to clinical outcomes. Methods This prospective observational study recruited patients hospitalized with AECOPD from November 2016 to July 2020. The eligible patients were divided into four groups according to their blood eosinophil counts at admission and discharge: persistently < 300 cells/μl (LL), < 300 cells/μl at admission but ≥ 300 cells/µl at discharge (LH), ≥ 300 cells/μl at admission but < 300 cells/µl at discharge (HL), and persistently ≥ 300 cells/μl (HH). Cox hazard analyses were used to study the association between eosinophil changes and exacerbations or mortality. Results In 530 patients included, 90 (17.0%) had a high blood eosinophil count (BEC) ≥ 300 cells/µl at admission but 32 (35.6%) of them showed a decreased BEC at discharge. The proportions and distribution for group LL, LH, HL, and HH were 381 (71.9%), 59 (11.1%), 32 (6.0%), and 58 (10.9%), respectively. During hospitalization, the LH group had a higher C-reactive protein level, higher rate of intensive care unit (ICU) admission, and higher total cost. The length of hospital stay of the LH group was longer compared with group LL, HL, or HH (P = 0.002, 0.017, and 0.001, respectively). During a follow-up of 12 months, the HH group was associated with a higher risk of moderate-to-severe exacerbations compared to the LL group (hazard ratio 2.00, 95% confidence interval 1.30–3.08, P = 0.002). Eosinophil changes had no significant association with mortality at 12 months. Sensitivity analyses in patients without asthma and without use of systemic corticosteroids prior to admission did not alter the results. Conclusions More attention should be paid to the LH group when evaluating the short-term prognosis of AECOPD. A persistently high BEC was a risk factor for long-term exacerbations. Eosinophil changes during hospitalization could help to predict outcomes.Yanan CuiWenye ZhangYiming MaZijie ZhanYan ChenBMCarticleCOPDExacerbationEosinophilStabilityMortalityDiseases of the respiratory systemRC705-779ENRespiratory Research, Vol 22, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic COPD
Exacerbation
Eosinophil
Stability
Mortality
Diseases of the respiratory system
RC705-779
spellingShingle COPD
Exacerbation
Eosinophil
Stability
Mortality
Diseases of the respiratory system
RC705-779
Yanan Cui
Wenye Zhang
Yiming Ma
Zijie Zhan
Yan Chen
Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study
description Abstract Background The clinical value of blood eosinophils and their stability in chronic obstructive pulmonary disease (COPD) remains controversial. There are limited studies on association between the stability of blood eosinophils in acute exacerbation of COPD (AECOPD) and clinical outcomes. This study aimed to evaluate the stability of blood eosinophils in hospitalized AECOPD and its relationship to clinical outcomes. Methods This prospective observational study recruited patients hospitalized with AECOPD from November 2016 to July 2020. The eligible patients were divided into four groups according to their blood eosinophil counts at admission and discharge: persistently < 300 cells/μl (LL), < 300 cells/μl at admission but ≥ 300 cells/µl at discharge (LH), ≥ 300 cells/μl at admission but < 300 cells/µl at discharge (HL), and persistently ≥ 300 cells/μl (HH). Cox hazard analyses were used to study the association between eosinophil changes and exacerbations or mortality. Results In 530 patients included, 90 (17.0%) had a high blood eosinophil count (BEC) ≥ 300 cells/µl at admission but 32 (35.6%) of them showed a decreased BEC at discharge. The proportions and distribution for group LL, LH, HL, and HH were 381 (71.9%), 59 (11.1%), 32 (6.0%), and 58 (10.9%), respectively. During hospitalization, the LH group had a higher C-reactive protein level, higher rate of intensive care unit (ICU) admission, and higher total cost. The length of hospital stay of the LH group was longer compared with group LL, HL, or HH (P = 0.002, 0.017, and 0.001, respectively). During a follow-up of 12 months, the HH group was associated with a higher risk of moderate-to-severe exacerbations compared to the LL group (hazard ratio 2.00, 95% confidence interval 1.30–3.08, P = 0.002). Eosinophil changes had no significant association with mortality at 12 months. Sensitivity analyses in patients without asthma and without use of systemic corticosteroids prior to admission did not alter the results. Conclusions More attention should be paid to the LH group when evaluating the short-term prognosis of AECOPD. A persistently high BEC was a risk factor for long-term exacerbations. Eosinophil changes during hospitalization could help to predict outcomes.
format article
author Yanan Cui
Wenye Zhang
Yiming Ma
Zijie Zhan
Yan Chen
author_facet Yanan Cui
Wenye Zhang
Yiming Ma
Zijie Zhan
Yan Chen
author_sort Yanan Cui
title Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study
title_short Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study
title_full Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study
title_fullStr Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study
title_full_unstemmed Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study
title_sort stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study
publisher BMC
publishDate 2021
url https://doaj.org/article/98b9ce1a4842486e8cacc243d007e447
work_keys_str_mv AT yanancui stabilityofbloodeosinophilsinacuteexacerbationofchronicobstructivepulmonarydiseaseanditsrelationshiptoclinicaloutcomesaprospectivecohortstudy
AT wenyezhang stabilityofbloodeosinophilsinacuteexacerbationofchronicobstructivepulmonarydiseaseanditsrelationshiptoclinicaloutcomesaprospectivecohortstudy
AT yimingma stabilityofbloodeosinophilsinacuteexacerbationofchronicobstructivepulmonarydiseaseanditsrelationshiptoclinicaloutcomesaprospectivecohortstudy
AT zijiezhan stabilityofbloodeosinophilsinacuteexacerbationofchronicobstructivepulmonarydiseaseanditsrelationshiptoclinicaloutcomesaprospectivecohortstudy
AT yanchen stabilityofbloodeosinophilsinacuteexacerbationofchronicobstructivepulmonarydiseaseanditsrelationshiptoclinicaloutcomesaprospectivecohortstudy
_version_ 1718407971462971392